Nuclear proliferation Alliance of Nuclear Weapons and Nuclear Power", tritium is not classified as a "special nuclear material" but rather as a by-product. It is seen as an important litmus test on the seriousness of the United States' intention to nuclear disarm. This radioactive super-heavy hydrogen isotope is used to boost the efficiency of fissile materials in nuclear weapons. The United States resumed tritium production in 2003 for the first time in 15 years. This could indicate that there is a potential nuclear arm stockpile replacement since the isotope naturally decays. In May 1995, NPT parties reaffirmed their commitment to a Fissile
Board of Radiation and Isotope Technology also manufactures self-luminescent tritium filled sources. The organisation also develops radiation-based medical equipment to treat cancer. BRIT operates three radiation facilities, one of them a spice and allied products irradiation facility in Vashi and another a "Krushak" (Krishi Utpadan Sanrakshan Kendra) radiation processing plant at Nashik. G. Ganesh is BRIT's Chief Executive officer since 1 August 2015, succeeding Anil Kumar Kohli (2006-2015). Board of Radiation and Isotope Technology Board of Radiation and Isotope Technology in short known as "BRIT" is a unit of the Department of Atomic Energy with its headquarters in Navi Mumbai, India. It is involved in production,